|
End-of-day quote
Korea S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 1,920.00 KRW | -2.98% |
|
-6.57% | -75.34% |
| Market Cap | 45.2B 32.61M 27.93M 26.14M 23.93M 44.9M 3.12B 45.5M 309M 120M 1.57B 122M 120M 5.18B | P/E 2024 |
-0.79x | P/E 2025 | -0.6x |
|---|---|---|---|---|---|
| Enterprise Value | 222B 160M 137M 129M 118M 221M 15.35B 224M 1.52B 592M 7.71B 602M 589M 25.51B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 3.82x |
| Free-Float |
47.93% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.98% | ||
| 1 week | -6.57% | ||
| Current month | -9.43% | ||
| 1 month | -3.03% | ||
| 3 months | -44.35% | ||
| 6 months | -66.32% | ||
| Current year | -75.34% |
| 1 week | 1,874 |  | 2,025 |
| 1 month | 1,874 | | 2,350 |
| Current year | 1,869 | | 8,490 |
| 1 year | 1,869 | | 10,395 |
| 3 years | 1,869 | | 83,850 |
| 5 years | 1,869 | | 204,750 |
| 10 years | 1,869 | | 858,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jae-Seob Kim
CEO | Chief Executive Officer | 63 | 13/10/2023 |
Jung-Chool Kim
CEO | Chief Executive Officer | 70 | 01/04/2012 |
Jong-Soo Kang
SAM | Sales & Marketing | 62 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Chool Kim
BRD | Director/Board Member | 70 | 01/04/2012 |
Dong-Chul Shin
BRD | Director/Board Member | 65 | 23/03/2020 |
Jae-Seob Kim
BRD | Director/Board Member | 63 | 13/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/6/24 | Fiscal year | Executive/Senior Manager | 6,183 | 0.0046% | ||
| 28/6/24 | Expiration | Chief Executive Officer | 21,884 | 0.0164% | ||
| 28/6/24 | Fiscal year | 11,846 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.98% | -6.57% | -79.29% | -97.56% | 32.61M | |
| +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | |
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | |
| +1.02% | +5.77% | +43.63% | +48.43% | 374B | |
| +0.85% | +4.07% | +24.97% | +40.58% | 302B | |
| +1.26% | +6.81% | +2.27% | +14.41% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | |
| +1.59% | +2.09% | -17.33% | -52.62% | 208B | |
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | |
| Average | +0.86% | +3.82% | +20.41% | +38.34% | 379.99B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.26% | +72.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 67.38B 48.62M 41.65M 38.97M 35.67M 66.94M 4.65B 67.83M 460M 180M 2.34B 183M 179M 7.73B | 73.23B 52.84M 45.26M 42.35M 38.77M 72.75M 5.06B 73.71M 500M 195M 2.54B 198M 194M 8.4B |
| Net income | -105B -75.75M -64.89M -60.71M -55.58M -104M -7.25B -106M -717M -280M -3.64B -284M -278M -12.04B | -170B -123M -105M -98.51M -90.17M -169M -11.76B -171M -1.16B -454M -5.91B -461M -451M -19.54B |
| Net Debt | 116B 83.48M 71.51M 66.91M 61.25M 115M 7.99B 116M 791M 308M 4.01B 313M 307M 13.27B | 177B 128M 110M 102M 93.79M 176M 12.23B 178M 1.21B 472M 6.14B 480M 470M 20.32B |
Employees
379
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | KRW 1,920.00 | -2.98% | 61,329 |
| 20/08/26 | KRW 1,979.00 | +3.83% | 56,205 |
| 19/08/26 | KRW 1,906.00 | -2.16% | 65,097 |
| 18/08/26 | KRW 1,948.00 | -5.21% | 124,952 |
| 14/08/26 | KRW 2,055.00 | 0.00% | 64,165 |
- Stock Market
- Stocks
- A003060 Stock
Select your edition
All financial news and data tailored to specific country editions
